The Anti-Inflammatory Effect of Different Doses of Aliskiren in Rat Models of Inflammation

References

• SahaA, AhmedM. The analgesic and anti-inflammatory activities of the extract of Albizia lebbeck in animal model. Pak J Pharm Sci. 2009;22(1):74–77.19168425
   PubMed Web of Science ®Google Scholar
• ChenL, DengH, CuiH, FangJ, ZuoZ. Inflammatory responses and inflammation-associated diseases in organs. 2018;9(6):7204–7218.
   Google Scholar
• LawrenceT. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1(6):1–11. doi:10.1101/cshperspect.a001651
   Web of Science ®Google Scholar
• SchneiderJP. Chronic musculoskeletal pain: rational use of opioid analgesics, Part 2. Consultant. 2010;50(10):142–148.
   Google Scholar
• HarirforooshS, AsgharW, JamaliF. Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Pharm Sci. 2013;16(5):821–847. doi:10.18433/j3vw2f24393558
   PubMed Web of Science ®Google Scholar
• OrayM, Abu SamraK, EbrahimiadibN, MeeseH, FosterCS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15(4):457–465. doi:10.1517/14740338.2016.114074326789102
   PubMed Web of Science ®Google Scholar
• PacurariM, KafouryR, TchounwouPB, NdebeleK. The renin-angiotensin-aldosterone system in vascular inflammation and remodeling. Int J Inflam. 2014;2014:689360. doi:10.1155/2014/68936024804145
   PubMedGoogle Scholar
• PimentaOS. Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors. Ther Clin Risk Manag. 2009;459. doi:10.2147/TCRM.S570219707255
   PubMedGoogle Scholar
• NguyenG, DelarueF, BurckléC, BouzhirL, GillerT, SraerJ-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109(11):1417–1427. doi:10.1172/jci1427612045255
   PubMed Web of Science ®Google Scholar
• ŠunjićV, ParnhamMJ. Aliskiren Fumarate In: Signposts to Chiral Drugs. Basel: Springer Basel;2011:13–27. doi:10.1007/978-3-0348-0125-6_2
   Google Scholar
• OliveiraSHP, BritoVGB, FrasnelliSCT, et al. Aliskiren attenuates the inflammatory response and wound healing process in diabetic mice with periodontal disease. Front Pharmacol. 2019;10:(July):1–16. doi:10.3389/fphar.2019.00708
   Web of Science ®Google Scholar
• PatelRB, PawarVD, PrajapatiKD, et al. Anti-nociceptive and anti-allodynic activity of aliskiren in various pain models. Eur J Pharmacol. 2013;708(1–3):80–87. doi:10.1016/j.ejphar.2013.03.03623545357
   PubMed Web of Science ®Google Scholar
• KaushikD, KumarA, KaushikP, RanaAC. Analgesic and anti-inflammatory activity of pinus roxburghii sarg. Adv Pharmacol Sci. 2012;245431. doi:10.1155/2012/24543122761611
   PubMedGoogle Scholar
• LagishettyC, NaikS. Polyamines: potential anti-inflammatory agents and their possible mechanism of action. Indian J Pharmacol. 2008;40(3):121–125. doi:10.4103/0253-7613.4230520040939
   PubMed Web of Science ®Google Scholar
• ChangJY, LewisA. Pharmacological Methods in the Control of Inflammation. A.R. Liss; 1989.
   Google Scholar
• LijuVB, JeenaK, KuttanR. An evaluation of antioxidant, anti-inflammatory, and antinociceptive activities of essential oil from Curcuma longa. L. Indian J Pharmacol. 2011;43(5):526–531. doi:10.4103/0253-7613.8496122021994
   PubMed Web of Science ®Google Scholar
• XueB, YuY, ZhangZ, et al. Leptin mediates high-fat diet sensitization of angiotensin II-elicited hypertension by upregulating the brain renin-angiotensin system and inflammation. Hypertension. 2016;67(5):970–976. doi:10.1161/HYPERTENSIONAHA.115.0673627021010
   PubMed Web of Science ®Google Scholar
• ZablockiD, SJ. Angiotensin II and oxidative stress in the failing heart. Antioxidants Redox Signal. 2013;19(10):1095–1109. doi:10.1089/ars.2012.4588
   PubMed Web of Science ®Google Scholar
• Cortes-PenfieldNW, BarbaraW, TrautnerRJ. Inflammation as a regulator of the renin-angiotensin system and blood pressure. Physiol Behav. 2017;176(5):139–148. doi:10.1016/j.physbeh.2017.03.04028363838
   PubMed Web of Science ®Google Scholar
• DrawzP, GhaziL. Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy. F1000Research. 2017;6. doi:10.12688/f1000research.9692.1
   Google Scholar
• ParameswaranN, PatialS. Tumor necrosis factor-a signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20(2):87–103. doi:10.1615/CritRevEukarGeneExpr.v20.i2.1021133840
   PubMed Web of Science ®Google Scholar
• PatelRB. Anti-cytokine and anti-hyperalgesic effects of aliskiren in experimental models of inflammation. 2014;4(1):125–133.
   Google Scholar
• SeverPS, GradmanAH, AziziM. Managing cardiovascular and renal risk: the potential of direct renin inhibition. J Renin-Angiotensin-Aldosterone Syst. 2009;10(2):65–76. doi:10.1177/147032030910466219502253
   PubMed Web of Science ®Google Scholar
• MüllerDN, LuftFC. Direct renin inhibition with aliskiren in hypertension and target organ damage. Clin J Am Soc Nephrol. 2006;1(2):221–228. doi:10.2215/CJN.0120100517699210
   PubMed Web of Science ®Google Scholar
• SabatR, GrützG, WarszawskaK, et al. Biology of interleukin-10. Cytokine Growth Factor Rev. 2010;21(5):331–344. doi:10.1016/j.cytogfr.2010.09.00221115385
   PubMed Web of Science ®Google Scholar
• KoF, YuQ, XueQL, et al. Inflammation and mortality in a frail mouse model. Age (Omaha). 2012;34(3):705–715. doi:10.1007/s11357-011-9269-6
   Google Scholar
• HanadaT, YoshimuraA. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 2002;13(4–5):413–421. doi:10.1016/S1359-6101(02)00026-612220554
   PubMed Web of Science ®Google Scholar
• RislerN, CastroC, CruzadoM, GonzálezS, MiatelloR. Early changes in proteoglycans production by resistance arteries smooth muscle cells of hypertensive rats. Am J Hypertens. 2002;15(5):416–421. doi:10.1016/S0895-7061(02)02263-X12022244
   PubMed Web of Science ®Google Scholar
• CruzadoMC, RislerNR, MiatelloRM, YaoG, SchiffrinEL, TouyzRM. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation. Am J Hypertens. 2005;18(1):81–87. doi:10.1016/j.amjhyper.2004.09.00115691621
   PubMed Web of Science ®Google Scholar
• PaulM, MehrAP, KreutzR. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747–803. doi:10.1152/physrev.00036.200516816138
   PubMed Web of Science ®Google Scholar
• AmesMK, AtkinsCE, PittB. The renin-angiotensin-aldosterone system and its suppression. J Vet Intern Med. 2019;33(2):363–382. doi:10.1111/jvim.1545430806496
   PubMed Web of Science ®Google Scholar
• KarakousisK, PinakasV, KontovosL, GavraM, PinakaO. Pleiotropic effect of aliskiren in reducing levels of hscrp and fibrinogen when added as treatment in patients previously in treatment with valsartan and amlodipine plus valsartan: PP.24.484. J Hypertens. 2010;28:e391. doi:10.1097/01.hjh.0000379410.77854.c9
   Web of Science ®Google Scholar